Single-cell and spatial transcriptomics approaches of cardiovascular development and disease

Abstract

Recent advancements in the resolution and throughput of single-cell analyses, including single-cell RNA sequencing (scRNA-seq), have achieved significant progress in biomedical research in the last decade. These techniques have been used to understand cellular heterogeneity by identifying many rare and novel cell types and characterizing subpopulations of cells that make up organs and tissues. Analysis across various datasets can elucidate temporal patterning in gene expression and developmental cues and is also employed to examine the response of cells to acute injury, damage, or disruption. Specifically, scRNA-seq and spatially resolved transcriptomics have been used to describe the identity of novel or rare cell subpopulations and transcriptional variations that are related to normal and pathological conditions in mammalian models and human tissues. These applications have critically contributed to advance basic cardiovascular research in the past decade by identifying novel cell types implicated in development and disease. In this review, we describe current scRNA-seq technologies and how current scRNA-seq and spatial transcriptomic (ST) techniques have advanced our understanding of cardiovascular development and disease. [BMB Reports 2020; 53(8): 393-399]

High Resolution Slide-seqV2 Spatial Transcriptomics Enables Discovery of Disease-Specific Cell Neighborhoods and Pathways

“…Spatial transcriptomics has revolutionized the field of single cell genomics and provided new insights into many biological systems such as the brain, heart, liver, and testes [82][83][84][85][86][87][88] . However, the potential of spatial transcriptomics to identify therapeutically actionable pathways has not yet been explored.…”

Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics

“…These spatially defined tissue studies using single-cell RNA-seq can show how different cell types could be targeted for their modified state. Even with the innovation and excitement for spatial transcriptomics studies, there still are trade-offs in utilizing these experiments for mechanistic inference ( 29 ). Depending on the question, if a tissue is too large, certain information could be missed if multiple spaces are not covered or considered for analysis, leading to biases.…”

The metabolic-epigenetic nexus in type 2 diabetes mellitus

“…Other single-cell epigenome profiling techniques exist through chromatin immunoprecipitation sequencing (ChIP-seq), DNase I hypersensitive site sequencing (DNase-seq), cleavage under targets and release using nuclease (CUT&RUN), and cleavage under targets & tagmentation (CUT&Tag) (Ma and Zhang, 2020). Using scRNA-seq tools, one can also spatially resolve transcriptomics to identify cell subpopulations and transcriptional variations related to human tissues in disease such as T2DM (Roth et al, 2020).…”